Comparison of marrow vs blood-derived stem cells for autografting in previously untreated multiple myeloma
1997

Comparing Stem Cells from Marrow and Blood for Myeloma Treatment

Sample size: 63 publication Evidence: moderate

Author Information

Author(s): N Raje, R Powles, C Horton, B Millar, V Shepherd, G Middleton, S Kulkarni, T Eisen, J Mehta, S Singhal, J Treleaven

Primary Institution: Royal Marsden Hospital

Hypothesis

Is there a difference in outcomes between autologous bone marrow transplants and peripheral blood stem cell transplants in multiple myeloma patients?

Conclusion

Patients receiving peripheral blood stem cell transplants had faster recovery and shorter hospital stays, but overall survival and relapse rates were similar to those receiving bone marrow transplants.

Supporting Evidence

  • Platelet recovery was significantly faster in PBSCT patients (19 days) compared to ABMT patients (33 days).
  • The median overall survival at 3 years was 76.9% for ABMT and 85.3% for PBSCT.
  • PBSCT patients spent fewer days in the hospital (median 20 days) compared to ABMT patients (median 27 days).
  • The complete remission rate was 84% for ABMT and 70% for PBSCT, but this difference was not statistically significant.

Takeaway

This study looked at two types of stem cell transplants for treating myeloma. One type helped patients recover faster and stay in the hospital less time, but both types worked about the same in keeping patients healthy long-term.

Methodology

Patients received either autologous bone marrow transplants or peripheral blood stem cell transplants after chemotherapy, and their recovery and outcomes were compared.

Limitations

The study was conducted at a single center, which may limit the generalizability of the results.

Participant Demographics

Patients were new and untreated multiple myeloma patients under the age of 70, with a median age of 50 years.

Statistical Information

P-Value

0.0015 for platelet recovery, 0.00001 for hospital stay duration

Confidence Interval

95% CI 60-93% for ABMT, 95% CI 72-99% for PBSCT

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication